The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 29, 2022
Filed:
Mar. 20, 2019
Applicant:
Tufts Medical Center, Inc., Boston, MA (US);
Inventors:
Adel M. Malek, Weston, MA (US);
Carl Heilman, Wayland, MA (US);
Assignee:
Tufts Medical Center, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/05 (2006.01); A61B 5/00 (2006.01); A61N 1/365 (2006.01); A61N 5/06 (2006.01); A61N 7/00 (2006.01); A61B 5/03 (2006.01); A61B 5/1455 (2006.01); A61B 5/07 (2006.01); A61N 1/375 (2006.01); A61N 1/36 (2006.01); A61B 5/01 (2006.01); A61B 5/145 (2006.01); A61B 5/11 (2006.01); A61B 5/16 (2006.01); A61B 17/00 (2006.01); A61B 90/00 (2016.01); A61B 5/291 (2021.01);
U.S. Cl.
CPC ...
A61B 5/6882 (2013.01); A61B 5/031 (2013.01); A61B 5/07 (2013.01); A61B 5/14553 (2013.01); A61N 1/0539 (2013.01); A61N 1/365 (2013.01); A61N 1/36139 (2013.01); A61N 1/37516 (2017.08); A61N 5/0601 (2013.01); A61N 7/00 (2013.01); A61B 5/002 (2013.01); A61B 5/0071 (2013.01); A61B 5/01 (2013.01); A61B 5/1126 (2013.01); A61B 5/14539 (2013.01); A61B 5/14546 (2013.01); A61B 5/165 (2013.01); A61B 5/291 (2021.01); A61B 5/4094 (2013.01); A61B 5/746 (2013.01); A61B 2017/00106 (2013.01); A61B 2090/064 (2016.02); A61B 2560/0214 (2013.01); A61N 2005/0602 (2013.01);
Abstract
An implant sized and shaped to be endovascularly delivered to the middle meningeal artery includes a carrier that carries a payload between first and second ends thereof. An anchor mechanism associated with the implant transitions into a swollen state in response to exposure to bodily fluids. In the swollen state, said anchor mechanism anchors the implant to the middle meningeal artery. Before or during the transition, the anchor mechanism permits endovascular delivery of the implant to the middle meningeal artery.